Our Pricing

Lowest Mounjaro Prices in the UK - Compare & Save

Published on: June 03, 2026

Searching for the lowest Mounjaro prices UK pharmacy options with transparent upfront costs? Cured Pharmacy offers genuine UK-licensed Mounjaro (tirzepatide) from £124.99, with free clinical consultations by UK prescribers and discreet next-day delivery. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) ensures every prescription meets MHRA standards, with no hidden fees and prices displayed before your consultation begins.

How Mounjaro Tirzepatide Works for Weight Loss

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed by the MHRA for weight management in the UK [1]. Unlike single-pathway treatments, tirzepatide simultaneously activates glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, producing synergistic effects on appetite regulation, insulin secretion, and energy expenditure.

In the SURMOUNT-1 clinical trial, participants receiving the 15mg maintenance dose achieved an average body weight reduction of 22.5% over 72 weeks—substantially higher than any previously approved obesity medication [1]. The dual-receptor mechanism enhances satiety signals in the hypothalamus whilst simultaneously improving insulin sensitivity and reducing hepatic glucose production [2].

Patients typically begin with a 2.5mg weekly dose, gradually escalating every four weeks to minimise gastrointestinal side effects. The maintenance doses range from 5mg to 15mg weekly, with your UK prescriber determining the optimal titration schedule based on your response and tolerability during clinical review.

Mounjaro Price Comparison: What You're Actually Paying For

When comparing lowest Mounjaro prices UK pharmacy options, understanding the full service package is essential. At Cured Pharmacy, the price from £124.99 includes the medication itself, a comprehensive clinical assessment by a UK-registered prescriber, ongoing prescription management, and discreet tracked delivery to your door.

Many patients initially focus solely on the advertised price per pen, but hidden consultation fees, mandatory subscription models, or undisclosed delivery charges can inflate total costs significantly. Our transparent pricing model displays the complete cost before you begin your consultation, with no compulsory subscriptions or recurring payment commitments.

The variation in Mounjaro pricing across UK pharmacies reflects differences in dose strength, pack size, and service inclusions. A single 2.5mg starter pen costs less than a four-week supply of 15mg maintenance pens, which is why accurate price comparison requires matching equivalent doses and treatment durations rather than comparing headline figures alone.

Understanding Dose-Specific Pricing

Your prescribed Mounjaro dose directly determines your monthly cost. Starter doses (2.5mg) require less active ingredient than maintenance doses (10mg or 15mg), creating natural price variations across the titration schedule. During your free consultation, our UK prescriber will outline the expected dose progression and associated costs for your entire treatment journey, ensuring no surprises when you reach higher maintenance doses.

Mounjaro vs Wegovy vs Saxenda: Clinical Outcomes Compared

All three medications belong to the incretin mimetic class, but their molecular structures and receptor activity profiles produce measurably different clinical outcomes. Mounjaro's dual GIP/GLP-1 action generated superior weight loss results compared to semaglutide (Wegovy) in head-to-head trials, with patients achieving an additional 5-7% body weight reduction on average [3].

Wegovy (semaglutide) acts exclusively on GLP-1 receptors and demonstrated 14.9% average weight loss over 68 weeks in the STEP-1 trial [4]. Saxenda (liraglutide), an earlier-generation GLP-1 agonist requiring daily injections, produced more modest results of 8% average weight loss over 56 weeks in the SCALE trial [5]. The enhanced efficacy of Mounjaro comes with comparable safety profiles across all three medications, though individual tolerability varies.

Your choice between these treatments depends on multiple factors beyond efficacy data: injection frequency preferences (weekly versus daily), previous treatment response, coexisting medical conditions, and budget considerations. Some patients respond exceptionally well to semaglutide-based treatments, whilst others achieve better outcomes with tirzepatide's dual mechanism—personalised prescribing by a UK clinician ensures the optimal match for your circumstances.

Side Effect Profiles Across GLP-1 Treatments

Gastrointestinal effects—nausea, diarrhoea, constipation, and reduced appetite—occur with all incretin-based therapies but typically diminish after the initial titration phase [1][4][5]. Mounjaro's gradual dose escalation protocol specifically aims to minimise these effects whilst your body adapts to the medication. Approximately 5-10% of patients discontinue treatment due to persistent gastrointestinal intolerance, though most find symptoms manageable with dietary modifications and proper hydration.

How to Access Mounjaro Through Cured Pharmacy

Mounjaro is a prescription-only medication in the UK, requiring clinical assessment by a registered prescriber before dispensing. Our streamlined online consultation takes under three minutes and covers your medical history, current medications, weight loss goals, and any contraindications that might affect prescribing decisions.

After submitting your consultation, a UK-registered prescriber reviews your responses within hours (typically the same working day). If Mounjaro is clinically appropriate and safe for you, they'll issue an NHS-standard FP10 prescription which our GPhC-registered pharmacy team (registration 9012511) dispenses immediately. Your medication ships in 100% discreet packaging with tracked delivery, typically arriving the next working day.

Patients ineligible for Mounjaro receive clear explanations and alternative treatment recommendations where appropriate. Common contraindications include personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, severe gastroparesis, or pregnancy. Your prescriber may suggest alternative weight management options better suited to your medical profile, ensuring safe and effective treatment regardless of which medication you ultimately receive.

Lowest Mounjaro Prices UK: Maximising Value Without Compromising Safety

Finding the lowest Mounjaro prices UK pharmacy options requires balancing cost against service quality, prescriber expertise, and medication authenticity. Cured Pharmacy's pricing from £124.99 reflects genuine UK-licensed Mounjaro sourced through authorised pharmaceutical wholesalers, not grey-market imports or counterfeit alternatives that occasionally appear through unregulated channels.

Beware of pricing that seems dramatically below market rates—counterfeit GLP-1 medications have been identified by the MHRA, some containing incorrect doses or no active ingredient whatsoever [6]. Legitimate UK pharmacies operate under strict GPhC regulations requiring proper cold-chain storage, batch tracking, and dispensing protocols that protect patient safety but create unavoidable baseline costs.

Our Lowest Prices Guaranteed commitment means if you find identical Mounjaro doses at a lower price from another UK-registered pharmacy, we'll match it. This guarantee applies to like-for-like comparisons: same dose strength, same pack size, and same service inclusions (consultation, prescription, delivery). Contact our pharmacy team on (+44) 116 4646009 with competitor pricing details for immediate price matching.

Payment Plans and Ongoing Treatment Costs

Weight loss with Mounjaro typically requires 6-12 months of continuous treatment to achieve and maintain target weight reduction. Our pharmacy team can discuss payment options and projected long-term costs during your consultation, helping you budget effectively for sustained treatment. Unlike subscription models that lock you into recurring charges, Cured Pharmacy allows flexible ordering—purchase monthly supplies as needed without contractual obligations or cancellation fees.

Clinical Monitoring and Ongoing Prescriber Support

Successful Mounjaro treatment extends beyond the initial prescription—regular clinical monitoring ensures safety, optimises dosing, and identifies any emerging concerns early. After starting treatment, your UK prescriber will schedule follow-up consultations every 4-8 weeks to assess weight loss progress, review side effects, and adjust your dose according to clinical response.

These follow-up consultations track key metrics including body weight, BMI changes, blood pressure, and subjective tolerability. If you experience persistent side effects or inadequate weight loss despite optimal dosing, your prescriber may recommend treatment modifications, additional lifestyle interventions, or alternative medications better suited to your needs [2].

Patients should contact their prescriber immediately if they develop severe abdominal pain, persistent vomiting, visual changes, or signs of pancreatitis—rare but serious complications requiring prompt medical evaluation. Our clinical team remains accessible throughout your treatment journey, providing expert guidance and safety monitoring that extends well beyond the initial prescription approval.

When to Expect Results

Most patients notice appetite suppression within the first week of starting Mounjaro, though measurable weight loss typically becomes evident after 4-8 weeks of treatment [1]. Maximum weight reduction generally occurs between 60-72 weeks of continuous therapy, with the rate of loss gradually plateauing as you approach your target weight. Combining Mounjaro with structured dietary changes and increased physical activity enhances outcomes beyond medication alone, with clinical trials showing additive benefits when pharmaceutical and lifestyle interventions work synergistically.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Frias, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519 [accessed 13 August 2026]
3. Ludvik, B., Giorgino, F., Jódar, E., et al. (2021). Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial. The Lancet, 398(10300), 583–598. https://doi.org/10.1016/S0140-6736(21)01443-4 [accessed 13 August 2026]
4. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
5. Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
6. Medicines and Healthcare products Regulatory Agency. (2024). Falsified Ozempic (semaglutide) pre-filled pens identified in the UK. Drug Safety Update, 17(9), A1. https://www.gov.uk/drug-safety-update/falsified-ozempic-semaglutide-pre-filled-pens [accessed 13 August 2026]
7. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
8. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
9. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Mounjaro is a prescription-only medication licensed by the MHRA for weight management in adults with a BMI ≥30 kg/m² or ≥27 kg/m² with weight-related comorbidities. Individual results vary and are not guaranteed. Always consult a qualified healthcare professional before starting any new medication. Side effects can occur—read the patient information leaflet carefully and report any concerns to your prescriber immediately.